| For: | Makary MS, Ramsell S, Miller E, Beal EW, Dowell JD. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons. World J Gastroenterol 2021; 27(43): 7462-7479 [PMID: 34887643 DOI: 10.3748/wjg.v27.i43.7462] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v27/i43/7462.htm |
| Number | Citing Articles |
| 1 |
Nojan Bajestani, Gavin Wu, Ahmed Hussein, Mina S. Makary. Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular Carcinoma. Biomedicines 2024; 12(7) doi: 10.3390/biomedicines12071432
|
| 2 |
Nourhan Assem, Kadry Mohammed El-Saeed, Sarah Ashraf Safwat, Dina Fathy Mohamed, Shereen Abdelmonaim Ibrahim, Heba Ahmed Faheem. APEX1 as a novel diagnostic and prognostic biomarker for hepatocellular carcinoma. The Egyptian Journal of Internal Medicine 2025; 37(1) doi: 10.1186/s43162-025-00449-2
|
| 3 |
Yasaman Rahimi, Geoge Sidrak, Kevin Kim. Digestive Disease Interventions. 2026; doi: 10.1007/978-3-032-03935-4_27
|
| 4 |
Farbod Fazlollahi, Mina S Makary. Precision oncology: The role of minimally-invasive ablation therapy in the management of solid organ tumors. World Journal of Radiology 2025; 17(1): 98618 doi: 10.4329/wjr.v17.i1.98618
|
| 5 |
Cody R Criss, Mina S Makary. Salvage locoregional therapies for recurrent hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(3): 413-424 doi: 10.3748/wjg.v29.i3.413
|
| 6 |
John Domini, Mina S. Makary. Single-center analysis of percutaneous ablation in the treatment of hepatocellular carcinoma: long-term outcomes of a 7-year experience. Abdominal Radiology 2023; doi: 10.1007/s00261-023-03819-y
|
| 7 |
Yanjun Gao, Yingge Li, Zheming Liu, Yi Dong, Siqi Yang, Bin Wu, Mengxia Xiao, Chen Chen, Yingmei Wen, Lei Chen, Haijuan Jiang, Yi Yao. AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway. Journal of Hepatocellular Carcinoma 2023; doi: 10.2147/JHC.S407680
|
| 8 |
Rong Cong, Bo Chen, Sai-Nan Cheng, Yi-Rui Zhai, Fan Wu, Bing Feng, Le-Yao Wang, Zhao-Wei Chen, Yong-Jian Zhu, Xiao-Hong Ma, Xin-Ming Zhao. Early recurrence risk stratification of hepatocellular carcinoma receiving preoperative radiotherapy: Incorporating clinical and imaging features across treatment phases. World Journal of Gastroenterology 2026; 32(23): 118308 doi: 10.3748/wjg.v32.i23.118308
Abstract(10) |
Core Tip(7) |
Full Article(HTML)(17)
|
Full Article (PDF)-1851K(4)
|
Full Article with Cover (PDF)-2235K(3)
|
Full Article (XML)-155K(3)
|
Audio-198K(4)
|
Peer-Review Report-237K(5)
|
Answering Reviewers-198K(5)
|
Supplementary Material-347K(4)
|
Times Cited (0)
|
Total Visits (39)
|
Open
|
| 9 |
Wen-jun Pei, Hao Zhou, Ying Zeng, Qi-lin Ji, Jing-jing Zhang, Xiu Wang. 3-Bromopyruvate modified with cholesterol enhances anti-hepatoma activity by inducing ferroptosis and apoptosis. Journal of Drug Delivery Science and Technology 2025; 103 doi: 10.1016/j.jddst.2024.106426
|
| 10 |
Lauren Matevish, Madhukar S. Patel, Parsia A. Vagefi. Downstaging Techniques for Hepatocellular Carcinoma in Candidates Awaiting Liver Transplantation. Surgical Clinics of North America 2024; 104(1) doi: 10.1016/j.suc.2023.07.004
|
| 11 |
Suyog Shaha, Danika Rodrigues, Samir Mitragotri. Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation. Journal of Controlled Release 2024; 367 doi: 10.1016/j.jconrel.2024.01.072
|
| 12 |
Nadine Abi-Jaoudeh, Ben Sadeghi, Hanna Javan, Jim Na, Graham Beaton, Fabio Tucci, Satheesh Ravula, David K. Imagawa. Drug-Eluting Embolic Loaded with Tyrosine Kinase Inhibitor Targeted Therapies for Transarterial Chemoembolization in a VX2 Model. Cancers 2023; 15(12) doi: 10.3390/cancers15123236
|
| 13 |
Mingqiang Liu. Effect of regorafenib combined with immunotherapy and arterial chemoembolization on the survival of patients with advanced hepatocellular carcinoma: a retrospective study. American Journal of Translational Research 2025; 17(3) doi: 10.62347/BXYO6569
|
| 14 |
Warren A. Campbell, Jeffrey F. B. Chick, David S. Shin, Mina S. Makary. Value of interventional radiology and their contributions to modern medical systems. Frontiers in Radiology 2024; 4 doi: 10.3389/fradi.2024.1403761
|
| 15 |
Valli De Re, Anna Rossetto, Alessandro Rosignoli, Elena Muraro, Vito Racanelli, Maria Lina Tornesello, Aron Zompicchiatti, Alessandro Uzzau. Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.897703
|
| 16 |
Maryam Farzaneh, Majid Ghasemian, Farhoodeh Ghaedrahmati, Jafar Poodineh, Sajad Najafi, Tariq Masoodi, Dedy Kurniawan, Shahab Uddin, Shirin Azizidoost. Functional roles of lncRNA-TUG1 in hepatocellular carcinoma. Life Sciences 2022; 308 doi: 10.1016/j.lfs.2022.120974
|
| 17 |
Hamzeh J. Al‐Ameer, Omayma Salim Waleed, S. Renuka Jyothi, Priya Priyadarshini Nayak, Siya Singla, Gurjant Singh, Annaev Umidjon, Azizjanov Khushnud Maksudovich, Manoj Kumar‐Mishra. Ginsenosides as Emerging Adjuvants for Immunotherapy in Gastrointestinal Cancers. Journal of Gastroenterology and Hepatology 2026; 41(5) doi: 10.1111/jgh.70333
|
| 18 |
Stephen Susman, Breanna Santoso, Mina S. Makary. Locoregional Therapies for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Biomedicines 2024; 12(10) doi: 10.3390/biomedicines12102226
|
| 19 |
Yi Qing, Yong Li. Research Progress on the Prediction of TACE Efficacy by Lipiodol Deposition. Journal of Biosciences and Medicines 2023; 11(11) doi: 10.4236/jbm.2023.1111022
|
| 20 |
Long-Bin Jeng, Horng-Ren Yang, Chiao-Fang Teng. Prognostic Biomarkers for Hepatocellular Carcinoma Patients Treated With Atezolizumab plus Bevacizumab Combination Therapy. Cancer Control 2025; 32 doi: 10.1177/10732748251339243
|
| 21 |
Elliott L. Fite, Mina S. Makary. Transarterial Chemoembolization Treatment Paradigms for Hepatocellular Carcinoma. Cancers 2024; 16(13) doi: 10.3390/cancers16132430
|
| 22 |
Kassem Sharif, Adi Lahat, Idan Levy, Shomron Ben Horin. Gastric Perforation After Microwave Ablation to Adjacent Hepatocellular Lesion. ACG Case Reports Journal 2023; 10(6) doi: 10.14309/crj.0000000000001082
|
| 23 |
Long-Bin Jeng, Fu-Ying Shih, Yu-Wen Liao, Woei-Cherng Shyu, Chiao-Fang Teng. Hypoxic tumor cell line lysate-pulsed dendritic cell vaccine exhibits better therapeutic effects on hepatocellular carcinoma. British Journal of Cancer 2025; 132(9) doi: 10.1038/s41416-025-02975-w
|
| 24 |
Hunter L. Gazda, Phuoc-Hanh D. Le, Ankit Patel, Arjun Jha, Mina S. Makary. Advances and Emerging Techniques in Transarterial Chemoembolization for Hepatocellular Carcinoma. Cancers 2026; 18(3) doi: 10.3390/cancers18030514
|
| 25 |
Sami Akbulut, Cemil Colak. Pioneering efficient deep learning architectures for enhanced hepatocellular carcinoma prediction and clinical translation. World Journal of Gastrointestinal Oncology 2026; 18(2): 113870 doi: 10.4251/wjgo.v18.i2.113870
|
| 26 |
Xiangxiang Lei, Xiaoge Hu, Qiliang Lu, Yingmin Yao, Wen Sun, Qiancheng Ma, Dongsheng Huang, Qiuran Xu. UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc. Biochemical and Biophysical Research Communications 2023; 638 doi: 10.1016/j.bbrc.2022.11.046
|
| 27 |
Warren A. Campbell, Mina S. Makary. Advances in Image-Guided Ablation Therapies for Solid Tumors. Cancers 2024; 16(14) doi: 10.3390/cancers16142560
|
| 28 |
Chen Guo, Randy Donelson, Zhengyu Wang, Amanda Billups, Tongjia Liu, Emma Torii, Danielle Burroughs, Marcus Flowers, Asheesh Shukla, Ryan Jeo, Davis Seelig, Chun Wang, Jafar Golzarian. Whey Protein-Based Hydrogel Microspheres for Endovascular Embolization. ACS Applied Bio Materials 2025; 8(1) doi: 10.1021/acsabm.4c00473
|
| 29 |
Roberto Iezzi, Alessandro Posa, Andrea Contegiacomo, In Joon Lee, Reto Bale, Alessandro Tanzilli, Lorenzo Tenore, Felice Giuliante, Antonio Gasbarrini, Shraga Nahum Goldberg, Tobias Jakobs, Maurizio Pompili, Irene Bargellini, Evis Sala, Hyo-Cheol Kim. Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives. Cancers 2023; 15(15) doi: 10.3390/cancers15153988
|
| 30 |
Xiaoying Xu, Yu Liu, Yanyan Liu, Yahan Yu, Mingqi Yang, Ligong Lu, Leung Chan, Bing Liu. Functional hydrogels for hepatocellular carcinoma: therapy, imaging, and in vitro model. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02547-9
|
| 31 |
Robin Schmidt, Christopher Rueger, Han Xu, Yubei He, Emine Yaren Yilmaz, Luisa Heidemann, Ornela Sulejmani, Yu Liu, Lasse Noack, Friederike Hesse, Richard Ruppel, Sara A. Abosabie, Charlie Alexander Hamm, Tobias Penzkofer, Bernhard Gebauer, Lynn Jeanette Savic. Comparing the Prognostic Value of Quantitative Response Assessment Tools and LIRADS Treatment Response Algorithm in Patients with Hepatocellular Carcinoma Following Interstitial High-Dose-Rate Brachytherapy and Conventional Transarterial Chemoembolization. Cancers 2025; 17(8) doi: 10.3390/cancers17081275
|
| 32 |
Marine Soret, Jacques-Antoine Maisonobe, Philippe Maksud, Stéphane Payen, Manon Allaire, Eric Savier, Charles Roux, Charlotte Lussey-Lepoutre, Aurélie Kas. Feasibility of Liver Transplantation after 90Y Radioembolization: Lessons from a Radiation Protection Incident. Health Physics 2024; 127(3) doi: 10.1097/HP.0000000000001814
|
| 33 |
Kelly Hao, Andrew J Paik, Lauren H Han, Mina S Makary. Yttrium-90 radioembolization treatment strategies for management of hepatocellular carcinoma. World Journal of Radiology 2024; 16(10): 512-527 doi: 10.4329/wjr.v16.i10.512
|
| 34 |
Josua A. Decker, Christian Scheurig-Muenkler, Jan H. Luitjens, Thomas Kroencke. Nationwide Trends and the Influence of Age and Gender in the In-Patient Care of Patients with Hepatocellular Carcinoma in Germany between 2010 and 2020. Cancers 2023; 15(10) doi: 10.3390/cancers15102792
|
| 35 |
Wen Luo, Li-Na Pang, Lu Han, Xiao-Bin Li, Xiao-Yu Li, Hai-Jing Liu, Xiao Yang, Lei Ding, Pei-Di Zhang, Jin Liu, Guang-Bin He, Xiao-Dong Zhou, Ming Yu. Percutaneous thermal ablation-based locoregional treatment for hepatocellular carcinoma larger than 3 cm: a 10-year single-center retrospective study. World Journal of Surgical Oncology 2026; 24(1) doi: 10.1186/s12957-026-04244-3
|
| 36 |
Guorong Jia, Tao Wang, Rou Li, Xiao Li, Gaofeng Sun, Wei Chen, Ye Peng, Chao Cheng, Jijin Yang, Changjing Zuo. Radioiodine‐131‐Labeled Theranostic Nanoparticles for Transarterial Radioembolization and Chemoembolization Combination Therapy of VX2 Liver Tumor. Advanced Healthcare Materials 2023; 12(32) doi: 10.1002/adhm.202301559
|
| 37 |
Shuangshuang Dou, Yunfei Huo, Minghui Gao, Quanwei Li, Buxin Kou, Mengyin Chai, Xiaoni Liu. Patient-derived xenograft model: Applications and challenges in liver cancer. Chinese Medical Journal 2025; 138(11) doi: 10.1097/CM9.0000000000003480
|
| 38 |
Ronald S. Arellano. Complications Associated with Image-Guided Percutaneous Thermal Ablation of Liver Tumors. Digestive Disease Interventions 2023; 7(03) doi: 10.1055/s-0042-1760372
|
| 39 |
Piaoyi Chen, Qinglin Xiao, Zhaoxiong Guo, Wei Liang, Ou Liu, Liteng Lin, Yugang Huang, Kangshun Zhu, Guodong Ye. Synthesis and characterization of 3-in-1 multifunctional lipiodol-doped Fe3O4@Poly (diallyl isophthalate) microspheres for arterial embolization, chemotherapy, and imaging. Biomedical Materials 2024; 19(3) doi: 10.1088/1748-605X/ad2c1a
|
| 40 |
Luca Grisetti, Clarissa J. C. Garcia, Anna A. Saponaro, Claudio Tiribelli, Devis Pascut. The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer. Cell Proliferation 2024; 57(8) doi: 10.1111/cpr.13641
|
| 41 |
Ramanpreet Singh, Mina S. Makary. Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Gastrointestinal Cancer 2025; 56(1) doi: 10.1007/s12029-025-01280-2
|
| 42 |
Leonardo Gomes da Fonseca, Raphael L C Araujo. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities. World Journal of Gastroenterology 2022; 28(28): 3573-3585 doi: 10.3748/wjg.v28.i28.3573
|
| 43 |
Maria Stella Franzè, Paul Vigneron, Anna Sessa, Carlo Saitta, Julia Chalaye, Vania Tacher, Alain Luciani, Hélène Regnault, Ancuta Bejan, Rami Rhaiem, Daniele Sommacale, Vincent Leroy, Raffaele Brustia, Giovanni Raimondo, Giuliana Amaddeo. Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy. Annals of Hepatology 2025; 30(1) doi: 10.1016/j.aohep.2024.101539
|
| 44 |
Andrei M. Jipa, Mina S. Makary. Locoregional Therapies for Hepatobiliary Tumors: Contemporary Strategies and Novel Applications. Cancers 2024; 16(7) doi: 10.3390/cancers16071271
|
| 45 |
Gavin Wu, Nojan Bajestani, Nooruddin Pracha, Cindy Chen, Mina S. Makary. Hepatocellular Carcinoma Surveillance Strategies: Major Guidelines and Screening Advances. Cancers 2024; 16(23) doi: 10.3390/cancers16233933
|
| 46 |
Long-Bin Jeng, Wen-Ling Chan, Chiao-Fang Teng. Prognostic Significance of Serum Albumin Level and Albumin-Based Mono- and Combination Biomarkers in Patients with Hepatocellular Carcinoma. Cancers 2023; 15(4) doi: 10.3390/cancers15041005
|
| 47 |
Faisal M. Sanai, Adnan Alzanbagi, Mohammed Arabi, Sarah S. Alfawaz, Khalid I. Bzeizi, Mohammed Almatrafi, Abdulmalik M. Alsabban, Jameel Bardesi, Hamdan S. Alghamdi, Mohamed Shawkat, Talal M. Alotaibi, Khairat H. Alameer, Shadi Saleem, Saad Abualganam, Abdulaziz M. Tashkandi, Noha H. Guzaiz, Nesreen H. Abourokbah, Hassan O. Alfakieh, Majed Almaghrabi, Abeer A. Alabdullah, Lujain H. Aljohani, Nuwayyir A. Alqasimi, Saad Aldosari, Azzam Khankan, Dieter Broering, Saleh A. Alqahtani. Transarterial Chemoembolization Outperforms Radioembolization in Early- and Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Retrospective Study. Cancers 2025; 17(13) doi: 10.3390/cancers17132254
|
| 48 |
Pan Liu, Xu Zhang, Qiang Fu, ChuanJiang Liu, QianKun Luo, PengFei Yu, Song Chen, HongWei Zhang, Tao Qin, Yuanwei Zhang. LINC01419 Promotes the Proliferation of Hepatoma Cells by Recruiting XRCC5 and Regulating Its Phosphorylation to Repair DNA Damage. Disease Markers 2022; 2022 doi: 10.1155/2022/9313680
|
| 49 |
Tumor-Derived Exosome miR-4661-5p Exerts Tumor-Promoting Effects in Hepatocellular Carcinoma by Targeting ESR1. Biology Bulletin 2025; 52(3) doi: 10.1134/S1062359024612230
|
| 50 |
Mina S. Makary, Jonathan Alexander, Luis E. Regalado, Sajid Jalil, Khalid Mumtaz, Jincheng Wang. Clinical outcomes of DEB-TACE in locally advanced hepatocellular carcinoma: A 5-year real world experience. PLOS ONE 2024; 19(9) doi: 10.1371/journal.pone.0309693
|
| 51 |
Elliott L. Fite, Mina S. Makary. Advances and Emerging Techniques in Y-90 Radioembolization for Hepatocellular Carcinoma. Cancers 2025; 17(9) doi: 10.3390/cancers17091494
|
| 52 |
Attila Kovács, Peter Bischoff, Hathal Haddad, Willi Zhou, Susanne Temming, Andreas Schäfer, Hannah Spallek, Lucas Kaupe, György Kovács, Michael Pinkawa. Long-Term Comparative Study on the Local Tumour Control of Different Ablation Technologies in Primary and Secondary Liver Malignancies. Journal of Personalized Medicine 2022; 12(3) doi: 10.3390/jpm12030430
|
| 53 |
Yuming Shi, Erfan Taherifard, Ali Saeed, Anwaar Saeed. MASLD-Related HCC: A Comprehensive Review of the Trends, Pathophysiology, Tumor Microenvironment, Surveillance, and Treatment Options. Current Issues in Molecular Biology 2024; 46(6) doi: 10.3390/cimb46060356
|
| 54 |
Bailey Hall, Zachary Ohs, Mario Dervishi, Alex Stevens, Christopher Sutter, Jon Davidson. Yttrium-90 combination therapies in hepatocellular carcinoma: current evidence and future directions. Hepatoma Research 2026; doi: 10.20517/2394-5079.2025.70
|
| 55 |
Zilin Li, Yan Wang, Jiahui Hu, Jingyang Du, Huizong Nie, Yiling Xi, Yue Huang, Kexin Wang, Kaixuan Zhang, Qiuran Xu, Liyan Cheng, Dongsheng Huang, Linglan Tu. USP28 knockdown and small molecule inhibitors promote KRT1 destabilization and sensitize hepatocellular carcinoma cells to sorafenib. Experimental Cell Research 2025; 448(2) doi: 10.1016/j.yexcr.2025.114558
|
| 56 |
Rong Cong, Fan Wu, Yirui Zhai, Feng Ye, Shuang Wang, Zhaowei Chen, Bing Feng, Leyao Wang, Yongjian Zhu, Sicong Wang, Xinming Zhao, Bo Chen, Xiaohong Ma. Can ADC changes help mRECIST or LI-RADS treatment response algorithm better diagnose pathological response of HCC after preoperative radiotherapy? Secondary analysis of a prospective phase 2 trial. Insights into Imaging 2025; 16(1) doi: 10.1186/s13244-025-02090-7
|
| 57 |
Elliott L. Fite, Nikhil Sekar, Jenish S. Venancius, Mina S. Makary. Hepatocellular Carcinoma Bridging and Downstaging: Advances in Locoregional Therapy. Biomedicines 2026; 14(4) doi: 10.3390/biomedicines14040877
|
| 58 |
Lixuan Tang, Xiao Yang, Liwen He, Chaogeng Zhu, Qingshan Chen. Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer. Lipids in Health and Disease 2025; 24(1) doi: 10.1186/s12944-024-02429-x
|
| 59 |
Sarah B. White, Dilip Rajasekhar Maddirela. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 3 doi: 10.1007/16833_2022_122
|
| 60 |
Yitong Li, Ruihang Zhang, Zhen Xu, Zhicheng Wang. Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer. International Journal of Nanomedicine 2022; doi: 10.2147/IJN.S349426
|